Intervention Review

You have free access to this content

Interventions for erythropoietin-resistant anaemia in dialysis patients

  1. Sunil V Badve1,*,
  2. Elaine M Beller2,
  3. Alan Cass3,
  4. Daniel P Francis4,
  5. Carmel Hawley1,
  6. Iain C Macdougall5,
  7. Vlado Perkovic3,
  8. David W Johnson1

Editorial Group: Cochrane Kidney and Transplant Group

Published Online: 26 AUG 2013

DOI: 10.1002/14651858.CD006861.pub3

How to Cite

Badve SV, Beller EM, Cass A, Francis DP, Hawley C, Macdougall IC, Perkovic V, Johnson DW. Interventions for erythropoietin-resistant anaemia in dialysis patients. Cochrane Database of Systematic Reviews 2013, Issue 8. Art. No.: CD006861. DOI: 10.1002/14651858.CD006861.pub3.

Author Information

  1. 1

    Princess Alexandra Hospital, Department of Nephrology, Woolloongabba, QLD, Australia

  2. 2

    Bond University, Faculty of Health Sciences and Medicine, Gold Coast, QLD, Australia

  3. 3

    The George Institute for Global Health, Renal and Metabolic Division, Camperdown, NSW, Australia

  4. 4

    Queensland Health, Central Regional Services, Division of the CHO, Stafford DC, QLD, Australia

  5. 5

    King's College Hospital, Renal Unit, London, UK

*Sunil V Badve, Department of Nephrology, Princess Alexandra Hospital, Woolloongabba, QLD, 4102, Australia.

Publication History

  1. Publication Status: New
  2. Published Online: 26 AUG 2013


Cited in:


This article has been cited by:

  1. 1
    Sunil V. Badve, Lei Zhang, Jeff S. Coombes, Elaine M. Pascoe, Alan Cass, Philip Clarke, Paolo Ferrari, Stephen P. McDonald, Alicia T. Morrish, Eugenie Pedagogos, Vlado Perkovic, Donna Reidlinger, Anish Scaria, Rowan Walker, Liza A. Vergara, Carmel M. Hawley, David W. Johnson, Association between Serum Alkaline Phosphatase and Primary Resistance to Erythropoiesis Stimulating Agents in Chronic Kidney Disease: A Secondary Analysis of the HERO Trial, Canadian Journal of Kidney Health and Disease, 2015, 2, 66